Metadata

Name CCU002_01 Antiplatelet medication
Type Disease or Syndrome
Group Disease or Syndrome
Data Sources





Clinical Terminologies British National Formulary (BNF)
Codelists covid_impact_ccu00201_antiplatelet_England_BNF.csv
Valid Event Data Range 01/01/1997 - 07/12/2020
Sex Female
Male
Authors Rochelle Knight, Venexia Walker, Samantha Ip, Jennifer A Cooper, Thomas Bolton, Spencer Keene, Rachel Denholm, Ashley Akbari, Hoda Abbasizanjani, Fatemeh Torabi, Efosa Omigie, Sam Hollings, Teri-Louise North, Renin Toms, Emanuele Di Angelantonio, Spiros Denaxas,, Johan H Thygesen, Christopher Tomlinson, Ben Bray, Craig J Smith, Mark Barber, George Davey Smith, Nishi Chaturvedi, Cathie Sudlow, William N Whiteley, Angela Wood, Jonathan A C Sterne,, CVD-COVID-UK/COVID-IMPACT consortium, Longitudinal Health and Wellbeing COVID-19 National Core Study
Agreement Date 24 Nov 2021
Version (UUID) Revision 1 (COVID-IMPACT)

Phenotypes

England primary care EHR: Antiplatelet medication

terminology code term
BNF 0209000L0AAAYAY Dipyridamole 200mg/5ml oral suspension sugar free
BNF 0209000C0AAADAD Clopidogrel 25mg/5ml oral suspension
BNF 0209000C0AAAKAK Clopidogrel 75mg/5ml oral suspension
BNF 0209000C0AAAIAI Clopidogrel 4mg oral powder sachets
BNF 0209000L0AAAKAK Dipyridamole 50mg/5ml oral suspension sugar free
BNF 0209000V0BCAAAA Molita 200mg/25mg modified-release capsules
BNF 0209000Z0AAACAC Ticagrelor 90mg orodispersible tablets sugar free
BNF 0209000A0BPAAAK Boots Aspirin 75mg gastro-resistant tablets
BNF 0209000L0AAAMAM Dipyridamole 200mg modified-release capsules
BNF 0209000A0BLAAAK Micropirin 75mg gastro-resistant tablets
BNF 0209000L0BBAGAM Persantin Retard 200mg capsules (Consilient Health)
BNF 0209000L0BIAAAM Trolactin 200mg modified-release capsules
BNF 0209000L0AAANAN Dipyridamole 200mg/5ml oral solution
BNF 0209000L0AAALAL Dipyridamole 50mg/5ml oral solution
BNF 0209000A0AAAKAK Aspirin 75mg gastro-resistant tablets
BNF 0209000Z0BBACAC Brilique 90mg orodispersible tablets
BNF 0209000A0AABABA Aspirin 25mg/5ml oral liquid
BNF 0209000C0AAAJAJ Clopidogrel 75mg/5ml oral solution
BNF 0209000L0AAAQAQ Dipyridamole 25mg/5ml oral liquid
BNF 0209000A0BQAAAB Danamep 75mg dispersible tablets
BNF 0209000C0AAAEAE Clopidogrel 300mg tablets
BNF 0209000Z0AAAAAA Ticagrelor 90mg tablets
BNF 0209000Y0AAABAB Prasugrel 10mg tablets
BNF 0209000Z0BBABAB Brilique 60mg tablets
BNF 0209000A0AAAJAJ Aspirin 75mg tablets
BNF 0209000Y0BCABAB Prafsia 10mg tablets
BNF 0209000C0BBAAAA Plavix 75mg tablets
BNF 0209000L0AAABAB Dipyridamole 25mg tablets
BNF 0209000V0BBAAAA Asasantin Retard capsules
BNF 0209000U0AAABAB Ticlopidine 250mg tablets
BNF 0209000C0BDAAAA Grepid 75mg tablets
BNF 0209000A0AABGBG Aspirin 75mg/5ml oral liquid
BNF 0209000Y0BBAAAA Efient 5mg tablets
BNF 0209000A0AABFBF Aspirin 30mg/5ml oral liquid
BNF 0209000Z0BBAAAA Brilique 90mg tablets
BNF 0209000L0BBABAC Persantin 100mg tablets
BNF 0209000L0BBAFAM Persantin Retard 200mg capsules (Boehringer Ingelheim)
BNF 0209000V0AAAAAA Dipyridamole 200mg modified-release / Aspirin 25mg capsules
BNF 0209000A0BNAAAB Pure Health Aspirin 75mg dispersible tablets
BNF 0209000L0BGAAAM Attia 200mg modified-release capsules
BNF 0209000A0BFAAAK Nu-Seals 75 gastro-resistant tablets
BNF 0209000C0AAALAL Clopidogrel 1mg/ml oral suspension
BNF 0209000A0AABIBI Aspirin 37.5mg/5ml oral liquid
BNF 0209000A0AABBBB Aspirin 40mg/5ml oral liquid
BNF 0209000C0BBABAE Plavix 300mg tablets
BNF 0209000Y0AAAAAA Prasugrel 5mg tablets
BNF 0209000A0BCAAAJ Angettes 75 tablets
BNF 0209000Y0BBABAB Efient 10mg tablets
BNF 0209000L0AAAHAH Dipyridamole 100mg/5ml oral liquid
BNF 0209000A0BRAAAB Mandaprin 75mg dispersible tablets
BNF 0209000A0AAA7A7 Aspirin 75mg effervescent tablets
BNF 0209000C0AAASAS Clopidogrel 5mg/5ml oral solution
BNF 0209000A0AAABAB Aspirin 75mg dispersible tablets
BNF 0209000L0AAACAC Dipyridamole 100mg tablets
BNF 0209000L0BHAAAM Ofcram PR 200mg capsules
BNF 0209000C0AAAAAA Clopidogrel 75mg tablets
BNF 0209000Z0AAABAB Ticagrelor 60mg tablets

Publication

Rochelle Knight, Venexia Walker, Samantha Ip, Jennifer A Cooper, Thomas Bolton, Spencer Keene, Rachel Denholm, Ashley Akbari, Hoda Abbasizanjani, Fatemeh Torabi, Efosa Omigie, Sam Hollings, Teri-Louise North, Renin Toms, Emanuele Di Angelantonio, Spiros Denaxas, Johan H Thygesen, Christopher Tomlinson, Ben Bray, Craig J Smith, Mark Barber, George Davey Smith, Nishi Chaturvedi, Cathie Sudlow, William N Whiteley, Angela Wood, Jonathan A C Sterne, for the CVD-COVID-UK/COVID-IMPACT consortium and the Longitudinal Health and Wellbeing COVID-19 National Core Study. Association of COVID-19 with arterial and venous vascular diseases: a population-wide cohort study of 48 million adults in England and Wales

medRxiv 2021.11.22.21266512; doi: https://doi.org/10.1101/2021.11.22.21266512